AI-generated summary
The authors used Monte Carlo light modeling and inverse calibration to guide transcranial photobiomodulation in APPswe/PS1dE9 mice, a model of Alzheimer's disease. They report that PBM improved spatial learning and memory and modulated amyloid burden, neuroinflammation, synaptic markers and neural network activity. Combined hippocampal irradiation at 810 and 1060 nm gave the most consistent responses. The authors note that intracerebral light exposure, not surface power alone, should be considered in protocol design.
- Who or what was studied
- APPswe/PS1dE9 mice (mouse model of Alzheimer's disease)
- Wavelengths
- 810, 1060 nm
- Limits stated in the abstract
- The study was conducted in mice and the abstract does not report a participant total or human data.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on link.springer.com.
Record from PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Wavelength
- 810 nm, 1060 nm
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Photobiomodulation, Dosimetry, Wavelength, Heterogeneity, Dose. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.